An Open-Label Exploratory Clinical Study to Evaluate the Safety and Potential Bioactivity of CLBS14 in Patients With Coronary Microvascular Dysfunction (CMD) and Without Obstructive Coronary Artery Disease
Phase of Trial: Phase II
Latest Information Update: 08 Nov 2018
At a glance
- Drugs CLBS-14 (Primary)
- Indications Cardiovascular disorders
- Focus Proof of concept; Therapeutic Use
- Sponsors Caladrius Biosciences
- 08 Nov 2018 According to a Caladrius Biosciences media release, this trial continue to enroll patients with a target for top-line data in the second half of 2019.
- 09 Aug 2018 According to Caladrius Biosciences media release, top line results are expected in early 2019.
- 24 Apr 2018 Status changed from planning to recruiting.